News
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled“ ...
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a ...
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...
CLDI Stock- Calidi Biotherapeutics raises $4.6M via discounted warrants to fund clinical programs and extend operational ...
Ladenburg Thalmann & Co, Inc. is acting as the exclusive placement agent for the offering.
Complete Calidi Biotherapeutics Inc. stock information by Barron's. View real-time CLDI stock price and news, along with industry-best analysis.
Stay up-to-date on Calidi Biotherapeutics, Inc. Common Stock (CLDI) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results